Synexus Interim Results 2006
05 December 2006
Interim results for the six months ended 30 September 2006
Highlights
- Turnover up 49% to £5.2m (2005: £3.5m)
- Operating Profit up 50% to £0.38m (2005: £0.25m)
- Operating Profit before Plc infrastructure costs up 215% to £0.8m (2005: £0.25m)
- Cash up 354% to £1.2m (2005: £0.3m)
- Successful integration of SCM (Poland) and DUH (Hungary) into the Group
- Conditional acquisition of Clinical Research Centres (SA) Pty in South Africa in October 2006
Mike Redmond, Chairman of Synexus, said:
"Our flotation provided us with a platform upon which to develop the Group and, in particular, our objective of rapid international expansion. This strategy has been vigorously pursued. As a result, we now offer our customers in the global pharmaceutical industry an ever more compelling service as we develop the capacity to deliver greater numbers of patients for high volume clinical trials at the lowest industry cost.
"The Group remains active in pursuing further opportunities to acquire profitable operations in other markets to continue the expansion of our capabilities to meet clients' needs."
View our Interim Results 2006 document